PBS Website Update - 1 April 2022
Page last updated: 1 April 2022
The Schedule of Pharmaceutical Benefits was updated on 1 April 2022 and the Summary of Changes can be found on the New, Amended and Deleted Items page.
The following updates have also been made to the PBS Website.
- Drugs subject to Price Disclosure - 1 April 2022
- Ex-manufacturer price - 1 April 2022
- Formulary Allocations - 1 April 2022
- First New Brand Price Reductions - 1 April 2022
- PBS Calendars - 1 April 2022
- Medicine Status Website - 1 April 2022
- 2022 April Cycle - Brand Price Reductions and Savings to Patients - 31 March 2022
- Drug Utilisation Sub-Committee (DUSC) Outcome Statement - 24 March 2022
- Drug Utilisation Sub-Committee (DUSC) Utilisation Analysis Public Release Documents - 24 March 2022
- PBS and RPBS Section 85 Date of Supply Data - 16 March 2022
- Listings on the PBS for Aboriginal and Torres Strait Islander people - 1 April 2022
- PBAC Public Summary Documents – November 2021 meeting (first time rejections and deferrals) - 18 March 2022
- 1 April 2022 Price Disclosure Confirmed Prices - 15 March 2022
- PBS Calendar - 15 March 2022
- PBAC Public Summary Documents – November 2021 meeting - 4 March 2022
- Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme - 1 March 2022
- Lagevrio® (molnupiravir) PBS listing - 1 March 2022
